Patient Voices
404 articles
Can a Pancreatic Cancer Screening Test Become a Reality?
Dr. Felice Schnoll-Sussman discusses screening options for pancreatic cancer and criteria for people who might want to get screened.
Studying a New Approach for the Liquid Biopsy
Drs. Allyson Ocean and Ying-Hsiu Su lead a liquid biopsy pilot study looking for KRAS proteins in urine, to detect pancreatic cancer.
One of the Luckiest Stage IV Pancreatic Cancer Patients Ever
Despite Stage IV diagnosis, Earl Groce got lucky with a quick diagnosis and acceptance to a clinical trial. Read Earl’s story about hope and a brighter future.
Testing a PARP Inhibitor for Metastatic Pancreatic Cancer Patients with DNA Repair Mutations
Researchers are testing a PARP inhibitor that is effective for cancers in pancreatic cancer patients with DNA repair mutations.
Testing the Addition of a New Drug to Radiation Therapy for Localized Pancreatic Cancer
In combination with radiation treatment, researchers are testing a new drug that causes DNA damage to make that treatment more effective.
Shedding Light on Chemo Brain
What is chemo fog or chemo brain? Are there techniques to counteract the side effects of chemotherapy on the brain?
Eating Right Can Help Your Pancreatic Cancer Fight
Pancreatic cancer patients can potentially combat side effects of treatment through a proper diet, according to advice from oncology dietitian Maria Petzel.
Chemotherapy in Comfort
Oncology nurse Heather Hannon offers her expertise to cancer patients in what is best to bring to treatments so you can pass the time in peace and comfort.
Adapting Cancer Medicine Is Key Part of Containing COVID-19
In an interview with OncLive, Dr. Allyson Ocean discusses the risks faced by cancer patients in treatment during the COVID-19 pandemic.
Managing the Side Effects of Pancreatic Cancer Treatment
Chemotherapy side effects can be uncomfortable. Dr. Laleh Melstrom outlines patient options for managing the various side effects for increased quality of life.
Understanding Who Is at High Risk for Pancreatic Cancer
Who is high-risk for pancreatic cancer? Oncologist Dr. Matthew Yurgelun explains high-risk populations and what steps to take if you meet the criteria.
Let’s Win Pancreatic Cancer Launches Updated Spanish Platform
Let’s Win is proud to announce the launch of it’s updated Spanish platform, with all the new features of the updated English platform.
Targeting the Undruggable KRAS Protein
Dr. Shubham Pant is focusing his research on effective treatments for the KRAS mutation, found in 90% of pancreatic cancers.
Two-Drug Combo Targets KRAS and Fights Resistance
Researcher Hervé Tiriac leads a clinical trial for a new drug combination targeting KRAS and chemotherapy resistance.
Precision Medicine from the Get-Go for Pancreatic Cancer
Dr. Ben George and colleagues at the Medical College of Wisconsin are using molecular profiling to determine the best chemotherapy for a patient’s pancreatic cancer.